Related Experiment Videos
Noninfectious mimics of community-acquired pneumonia
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0360.
Abstract:
A broad spectrum of diseases and clinical syndromes can masquerade as community-acquired pneumonia (CAP). Many such disorders, such as hypersensitivity pneumonitis (HP), chronic eosinophilic pneumonia (CEP), bronchiolitis obliterans--organizing pneumonia (BOOP), reactions to drugs or exogenous agents, systemic vasculitis, and alveolar hemorrhage (AH; pulmonary-renal) syndromes, are immune-mediated and warrant treatment with corticosteroids or immunosuppressive agents. In addition, rare neoplastic and lymphoproliferative disorders, and conditions of uncertain etiology (eg, pulmonary alveolar proteinosis [PAP]) may have clinical and radiographic features that overlap with infectious causes of pneumonia. Distinguishing infectious from noninfectious causes of pneumonia may be difficult, and requires the use of ancillary serologic studies and often histologic material to establish a precise etiologic diagnosis. For some of these disorders (particularly Wegener's granulomatosis [WG], systemic necrotizing vasculitis [SNV], and antiglomerular basement antibody disease [anti-GBM disease]), serologic markers are invaluable in confirming the diagnosis and monitoring the course of the disease. In this report, we review the salient clinical and histologic features of these diverse diseases, and present a diagnostic and therapeutic approach.
Insights
Many diseases mimic community-acquired pneumonia (CAP). Differentiating infectious from noninfectious causes requires serologic and histologic studies for accurate diagnosis and treatment.
Area of Science:
- Pulmonology
- Immunology
- Pathology
Background:
- Community-acquired pneumonia (CAP) can be mimicked by a wide range of non-infectious diseases.
- Immune-mediated disorders like hypersensitivity pneumonitis (HP) and vasculitis often present with CAP-like symptoms.
- Neoplastic, lymphoproliferative, and idiopathic conditions may also overlap radiographically and clinically with pneumonia.
Purpose of the Study:
- To review the clinical and histologic features of diverse non-infectious diseases that present as CAP.
- To outline a diagnostic and therapeutic strategy for distinguishing these conditions from infectious pneumonia.
- To highlight the role of serologic markers in diagnosing specific immune-mediated lung diseases.
Main Methods:
- Review of clinical and radiographic presentations of various non-infectious pulmonary disorders.
- Discussion of histopathologic findings crucial for differential diagnosis.
- Emphasis on ancillary serologic studies for specific conditions like Wegener's granulomatosis.
Main Results:
- Non-infectious etiologies frequently present with overlapping features to CAP, complicating diagnosis.
- Immune-mediated diseases often require immunosuppressive therapy, distinct from CAP treatment.
- Specific serologic markers are vital for diagnosing conditions such as anti-GBM disease and vasculitis.
Conclusions:
- Accurate diagnosis of CAP mimics requires careful consideration of non-infectious causes.
- Integration of clinical, histologic, and serologic data is essential for appropriate management.
- Early identification of immune-mediated lung diseases ensures timely and targeted corticosteroid or immunosuppressive therapy.